Last reviewed · How we verify
Jinlida granules
Jinlida granules is a Traditional Chinese medicine herbal formulation Small molecule drug developed by Shanghai Jiao Tong University School of Medicine. It is currently FDA-approved for Type 2 diabetes mellitus, Metabolic syndrome.
Jinlida granules is a traditional Chinese medicine formulation that modulates immune function and reduces inflammation to support metabolic health.
Jinlida granules are a small molecule intervention used to study conditions such as Type 2 Diabetes, Dyslipidemia, Obese Impaired Glucose Tolerance, and Newly Diagnosed Obese Type 2 Diabetic Patients. Jinlida granules are taken three times a day with hot water, as part of clinical trials to evaluate their efficacy and safety.
At a glance
| Generic name | Jinlida granules |
|---|---|
| Sponsor | Shanghai Jiao Tong University School of Medicine |
| Drug class | Traditional Chinese medicine herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Endocrinology/Metabolic Disease |
| Phase | FDA-approved |
Mechanism of action
As a herbal granule preparation, Jinlida works through multiple bioactive compounds that collectively enhance immune regulation and reduce systemic inflammation. The formulation is designed to improve glucose metabolism and support pancreatic function, though the precise molecular targets of individual constituents remain incompletely characterized in Western pharmacological terms.
Approved indications
- Type 2 diabetes mellitus
- Metabolic syndrome
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus (PHASE2)
- Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jinlida granules CI brief — competitive landscape report
- Jinlida granules updates RSS · CI watch RSS
- Shanghai Jiao Tong University School of Medicine portfolio CI
Frequently asked questions about Jinlida granules
What is Jinlida granules?
How does Jinlida granules work?
What is Jinlida granules used for?
Who makes Jinlida granules?
What drug class is Jinlida granules in?
What development phase is Jinlida granules in?
What are the side effects of Jinlida granules?
Related
- Drug class: All Traditional Chinese medicine herbal formulation drugs
- Manufacturer: Shanghai Jiao Tong University School of Medicine — full pipeline
- Therapeutic area: All drugs in Endocrinology/Metabolic Disease
- Indication: Drugs for Type 2 diabetes mellitus
- Indication: Drugs for Metabolic syndrome
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing